A multicenter, prospective, non-interventional study to investigate the treatment patterns of neratinib in human epidermal growth factor receptor 2 positive (HER2+) early breast cancer (EBC) in China: Interim analysis of the NER-Tree study

Category Primary study
JournalAnnals of Oncology
Year 2024
This article has no abstract
Epistemonikos ID: ffa5c913f7ccff656b404fd767a925b72f5c55e7
First added on: Feb 19, 2025